The aim of this study was to assess the safety and prognostic value of dipyridamole-201 Tl imaging very early after acute myocardial infarction in patients treated with thrombolytic therapy. Fifty-two consecutive patients with an uncomplicated clinical course underwent quantitative planar dipyridamole-20 'Tl imaging 2-5 days after acute myocardial infarction. The patients were followed for 14 ±7 months after discharge. No major complications occurred during the test. Of the 30 patients with redistribution, five (16-6%) developed in-hospital unstable angina as against none of the 22 patients without redistribution. During follow-up, a total of five late cardiac events were observed: two deaths and two cases of unstable angina in the group with reversible defects and one reinfarction in the group with fixed defects. The 1-year actuarial probability of being free of cardiac events was, respectively, 66 ± 10% and 94 ± 5% in the patients with and without redistribution
Introduction
Dipyridamole thallium-201 ( 20l Tl) imaging has been widely used for risk stratification early after acute myocardial infarction in the pre-thrombolytic era 1 '" 41 . Thrombolytic therapy has favourably influenced the natural history of acute myocardial infarction; studies involving large numbers of patients have shown that such treatment is capable of limiting the extension of acute myocardial infarction and of reducing both in-hospital and long-term mortality' 5 " 81 . Nevertheless, the incidence of recurrent ischaemic events after thrombolytic therapy remains high 16 ' 81 , particularly during the first week' 9101 . On the other hand, early angiography is reserved for those with persisting ischaemia 1 " 121 . The aim of the present study was to assess the safety and prognostic value of dipyridamole- 201 Tl imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy.
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Methods

Patient population
All of the 120 acute myocardial infarction patients admitted to our coronary care unit over a 1 year period who had received thrombolytic therapy were considered for inclusion in the study. The diagnosis of acute myocardial infarction was based on the combination of a prolonged ischaemic chest pain, typical ECG changes of infarction, and a characteristic rise and fall in plasma creatine kinase-MB activity. Of these, 49 patients were considered ineligible: six had recurrent angina (defined as pain at rest associated with ECG changes); 12 congestive heart failure (defined as the need for digoxin and furosemide therapy, bilateral rales halfway up the posterior fields or ventricular gallop); two malignant ventricular arrhythmias (Lown class >3); 17 underwent emergency coronary revascularization by angioplasty or surgery; one experienced a cerebral stroke; one developed a ventricular septal defect requiring surgery; nine were aged >80 years; and one had bronchospasm requiring theophylline treatment. Of the 71 eligible patients, 19 Data are expressed as mean value ± SD or number of patients (%). M = male; F = female; AMI = acute myocardial infarction; CK= creatine kinase.
were not recruited because of their refusal or the unavailability of thallium-201. Consequently, the study group consisted of 52 patients (43 men, nine women) aged 40 to 77 years (mean 58 ±10). All gave their informed consent. The study protocol was approved by the Research Ethical Committee of the Department of Cardiology of the Niguarda Hospital. The clinical characteristics of the study population are shown in Table 1 .
Dipyridamole-thallium-201 protocol and thallium-201 image acquisition
Dipyridamole was intravenously infused at a rate of 0-56 mg . kg" ' over 4 min and, 4 min later, 65-75 MBq of thallium-201 were injected. Theophylline was administered intravenously to all of the patients at the end of the early acquisitions (stress image acquisition) and the electrocardiogram (ECG) was continuously monitored by means of an oscilloscope. Blood pressure and 12 lead ECG were recorded before, and every minute during the first 20 min of the test. All of the studies were performed in the Division of Cardiology (in order to avoid the need to transport the patients to the Department of Nuclear Medicine) using a small-field mobile camera (Apex 210, MI Elscint) equipped with a low-energy, high-resolution, parallel hole collimator.
The quantitative assessment of the serial myocardial images obtained from each patient was performed according to the method described by Watson et a/. A myocardial segment was considered abnormal if it showed a persistent reduction in thallium activity of >25% in comparison with the segment with the greatest count intensity in that view. Redistribution was considered present if the ratio of activity in the segment with reduced activity vs that in the segment with the greatest activity was greater in the delayed than in the initial image. The 201 Tl images were interpreted by two independent observers who had no clinical information and were unaware of the results of other tests; the results of the 20l Tl imaging were not revealed to the physicians treating the patients in order to ensure that no management decision was made on the basis of scintigraphic data.
Exercise testing
A symptom-limited treadmill exercise test using the standard Bruce protocol was performed 10 to 14 days after acute myocardial infarction. The exercise tests were considered positive for ischaemia if typical angina pectoris developed or if the ECG showed a downsloping or horizontal ST segment depression of >01 mV from the baseline at 80 ms from the J point. Exercise was continued until one of the following endpoints occurred: chest pain, ST depression of >0-2 mV, dyspnoea, complex ventricular arrhythmias, a decrease in systolic blood pressure of >10 mmHg at two consecutive steps, or the inability of the patient to exercise further.
Cardiac catheterization
Standard multiple-view coronary arteriography was performed using the Judkins' technique. All of the angiograms were blindly reviewed by two independent observers and semiquantitatively analysed by measuring vessel diameters with calipers. A vessel was considered as having significant stenosis if its diameter was narrowed by > 50%. The flow pattern of the infarct-related vessel was graded according to the Thrombolysis in Myocardial Infarction (TIMI) trial classification' 141 . Contrast ventriculography was performed using the right anterior oblique projection.
Follow-up data
Follow-up data were obtained by means of a clinical control or telephone contact at a mean of 14 ± 7 months (range 1 to 27) after acute myocardial infarction. No patients were lost to follow-up. Cardiac events were defined as the development of cardiac death, myocardial infarction or unstable angina requiring hospitalization and revascularization. Coronary revascularization in itself was not considered an event because elective revascularization may be based on a number of factors. These may be coronary anatomy, the results of provocative tests, or the decision of the treating physicians. Any ischaemic event occurring after revascularization was excluded from the analysis.
Statistical analysis
The data are expressed as mean values ± standard deviation. Student's t-test was used to assess the differences Eur Heart J. Vol. 18. June 1997 during the test in 15 patients (28-8%); all of the symptoms or electrocardiographic changes were rapidly reversed by theophylline. 201 Tl perfusion resting defects were present in all 52 patients: 201 Tl redistribution was seen in 30 of the 52 patients (576%) (Group A) and fixed perfusion defects in the remaining 22 patients (Group B).
Exercise testing
A symptom-limited exercise test was carried out in 42 of the 52 patients before hospital discharge. Ten patients did not take part in the test because of recurrent unstable angina (five cases), physical limitation (four cases) and the presence of stable left bundle branch block (one case). Exercise testing was carried out off drugs in 24 patients; 18 patients were receiving medication (10 on angiotensin-converting enzyme inhibitors, seven on nitrates, one on beta-adrenergic blocking agents). Exercise testing was negative in 24 patients and positive in 18 (angina in four, ST depression in 13, both angina and ST depression in one), 11 of whom had 201 Tl redistribution.
between mean values and a P value of less than 005 was considered significant. Actuarial event-free rates were analysed using Kaplan-Meier survival curves with regard to the presence of 2O1 T1 redistribution, and the differences were assessed using the Mantel-Cox test. 
Angiographic data
Of the 35 patients who underwent angiography, nonobstructive coronary artery disease was found in one case; single-vessel disease in 10, multivessel disease in 24.
Multivessel disease was present in 18 of the 23 patients (78%) with reversible defects (multiple defects were present in three patients), as against six of the 12 patients (50%) without 201 Tl redistribution (P=ns). A TIMI grade 2 or 3 flow was demonstrated in 28 patients: 19 out of 22 (86%) with and nine out of 12 (75%) without 20l Tl redistribution (P=ns).
Results
The results are given in Table 2 .
Dipyridamole-201 Tl imaging
The dipyridamole20l Tl studies were performed at a mean of 41 ±0-8 days (range 2-5) after acute myocardial infarction. At the time of the test, 29 patients (55-8%) were receiving antianginal medication (24 on nitrates, three on beta-adrenergic blocking agents and two on calcium antagonists). No major complications (cardiac death, recurrent myocardial infarction, serious arrhythmias) occurred during the test. Minor dipyridamole side effects (mild hypotension, flushing and headache) were observed in 12 patients (23%). Chest pain, ST segment depression or elevation >01 mV developed
In-hospital clinical course and post-discharge
follow-up ( Fig. 1) No patient died during hospitalization. Among the 30 patients who had 2O1 T1 redistribution, in-hospital recurrent angina requiring urgent revascularization occurred in five patients (16-6%). No recurrent angina or reinfarction were observed in the 22 patients without redistribution. Twelve patients, 10 of whom had 201 Tl redistribution, underwent elective coronary revascularization (coronary angioplasty in seven cases, bypass surgery in five). The decision to perform revascularization was at the discretion of the treating physicians.
On follow-up, there were five cardiac events: two cardiac deaths (one case of sudden death and one fatal myocardial infarction) and two cases of unstable angina requiring revascularization in the group with reversible defects, and one case of reinfarction in the group with fixed defects. The probability of remaining event-free after the dipyridamole- 201 Tl study was 66 ±10% and 94 ± 5 % at 1 year, and 55 ± 13% and 94 ± 5 % after 2 years in the patients, respectively, with and without redistribution (P=001) (Fig. 2) .
After discharge, among the 32 patients who performed an exercise test and did not undergo coronary revascularization during hospitalization, one out of nine with a positive test was readmitted for unstable angina, and two out of 23 with a negative test had late cardiac events (one death and one unstable angina).
Among the clinical, scintigraphic, angiographic and exercise testing variables tested by univariate and multivariate analyses, the most reliable predictor of cardiac events was 201 Tl redistribution (Table 3 ).
Discussion
The results of the study confirm that dipyridamole-201 Tl imaging very early after acute myocardial infarction is a feasible and safe test, even in patients treated with thrombolytic therapy' 151 . None of the patients without 201 Tl redistribution sustained any in-hospital cardiac events; all of the in-hospital ischaemic events occurred in patients who had 2OI T1 redistribution. Furthermore, all but one cardiac event observed after discharge occurred in patients with reversible defects. The probability of remaining event-free after dipyridamole20l Tl study was 66 ±10% and 94 ± 5 % at 1 year, and 55 ± 13% and 94 ± 5% at 2 years in the patients, respectively, with and without redistribution (/ > =001). The use of this test in the first few days after acute myocardial infarction may have the advantage of allowing an early stratification of patients with different degrees of risk for in-hospital and late cardiac events. The absence of 2O1 T1 redistribution defines a population of patients at such a low risk for cardiac events that further diagnostic procedures may not be necessary. This would allow patients to be discharged early, a consequent substantial reduction in costs and better use of increasingly constrained resources.
On the other hand, the presence of a reversible defect may be useful in selecting patients who would benefit from further careful evaluation. However, the rather low positive-predictive value implies that many patients with redistribution do not subsequently experience a cardiac event. It is therefore unrealistic to expect all patients with a positive test to undergo invasive diagnostic or therapeutic procedures automatically. Our results are consistent with previous studies regarding risk stratification early after uncomplicated acute myocardial infarction using different alternative strategies. Topol et a/.' 161 used submaximal exercise testing 3 days after acute myocardial infarction in carefully selected patients with an uncomplicated clinical course and concluded that a negative test allowed early hospital discharge in these patients with a substantial reduction in hospital charges. But very early exercise testing appears to be feasible in only a few patients. In addition, previous experimental studies have aroused concern that early exercise could reduce healing in the infarct zone and lead to a thinning of the scar 1 '
71
. The major advantage of dipyridamole-20 'Tl imaging is the capacity, very early after acute myocardial infarction, to evaluate patients unable to perform adequate exercise. Dipyridamole-201 T1 imaging appears to be particularly well suited for studying patients within the first days after acute myocardial infarction. Dipyridamole infusion is associated with only modest changes in the determinants of myocardial oxygen demand and its haemodynamic effects are brief and rapidly reversed with theophylline. Another advantage of dipyridamole stress is that the results of the test are less affected by concomitant administration of antianginal medication when compared with exercise. In addition dipyridamole-20 'Tl imaging seems to be particularly useful in patients whose medications cannot be discontinued.
Chiarella et a/.
1 ' 81 studied a series of 251 consecutive patients undergoing dipyridamole echocardiography 3 days after acute myocardial infarction and found the test to be feasible, safe and capable of identifying patients at low risk for in-hospital events (sensitivity 94%, negative predictive value 97%). Dipyridamole echocardiography requires an acceptable acoustic window: the interpretation of stress echocardiography for the detection of myocardial ischaemia is easy in patients with normal or moderate hypokinesia at resting echocardiography, but much more difficult in those with severe hypokinesia or akinesia at rest. The main problem in these cases is whether the worsening of akinesia (becoming dyskinesia during stress) represents myocardial ischaemia or is mainly a mechanical phenomenon due to a systolic outward bulging secondary to a hyperdynamic contraction of the remaining myocardium'
191 .
In the present series, the patient without 201 Tl redistribution had a good prognosis, as demonstrated both with negative or positive pre-discharge exercise testing. Comparison between dipyridamole-20 'Tl imaging and exercise testing is not feasible in our series and was not the aim of this study: firstly because, unlike dipyridamole20l Tl imaging, the exercise tests were performed later and consequently excluded those patients with early events, making those who performed it a 'pre-stratified' group of patients with a lower event rate; secondly, the treating physicians had access to the exercise test results, and the presence of ischaemia influenced their decision to recommend revascularization, thus affecting any evaluation about its prognostic value.
Limitations of the study
Several limitations of the present study must be considered. The patients were evaluated using planar thallium scintigraphy, a method that may be less sensitive than tomographic imaging. Nevertheless, in clinical practice, Eur Heart J, Vol. 18, June 1997 planar imaging was shown to be accurate when patients were studied after acute myocardial infarction. As a consequence of the relatively small number of patients studied, and as can be expected in a low risk group of patients, the number of hard events was limited. The patients with 201 Tl redistribution could possibly have been stratified further in terms of severity and extent of defects.
Conclusions and clinical implications
Dipyridamole-201 T1 imaging 2-5 days after uncomplicated acute myocardial infarction is a feasible and safe test even in patients treated with thrombolytic therapy. In our experience, its use in the first days after acute myocardial infarction may have a significant advantage in allowing the early stratification of patients with different degrees of risk for in-hospital and late cardiac events. The patients with negative dipyridamole-201 Tl imaging appear to be at low risk and may be candidates for early discharge without the need for any further diagnostic procedures, thus leading to a substantial reduction in the cost of hospitalization. The presence of 2OI T1 redistribution identifies a subgroup of patients who may benefit from further careful clinical evaluation. Because of its relatively low positive predictive accuracy and because outcome in terms of hard events is relatively good after thrombolytic therapy, it seems unrealistic to offer coronary angiography to every patient with a positive test.
Further study in a larger number of patients is needed to validate the strategy of performing dipyridamole- 201 Tl imaging very early in the course of acute myocardial infarction. The benefits need to be confirmed and it should be ensured that patients receive the most effective and cost-effective strategy.
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